SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    US Cancer Statistics Working Group. United States Cancer Statistics: 2003 Incidence and Mortality. Atlanta, Ga: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2006. Available from URL: www.cdc.gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2003_Incidence_and_Mortality.pdf Accessed April 13, 2007.
  • 2
    Ryerson AB,Bernard VB,Major AC. National Breast and Cervical Cancer Early Detection Program: 1991–2002 National Report. Atlanta, Ga: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. Available from URL: http://www.cdc.gov/cancer/nbccedp/Reports/NationalReports/index.htm Accessed on January 20, 2007.
  • 3
    Centers for Disease Control and Prevention. The National Breast and Cervical Cancer Early Detection Program. Available from URL: http://www.cdc.gov/cancer/nbccedp/about. htm Accessed January 20, 2007.
  • 4
    Greene JC,Caracelli VJ,Graham WF. Toward a conceptual framework for mixed method evaluation designs. Educ Eval Policy Anal. 1989; 11: 255274.
  • 5
    French MT,Roebuck MC,McLellan AT. Cost estimation when time and resources are limited: the Brief DATCAP. J Subst Abuse Treat. 2004; 27: 187193.
  • 6
    French MT,Dunlap LJ,Zarkin GA,McGeary KA,McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment.The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat. 1997; 14: 445455.
  • 7
    Salome HJ,French MT,Miller M,McLellan AT. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug Alcohol Depend. 2003; 71: 195206.
  • 8
    Haddix AC,Corso PA,Gorsky DR. Costs. In: HaddixAC,TeutschSM,CorsoPA, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation,2nd ed. New York, NY: Oxford University Press; 2003: 5376.
  • 9
    Kerlinger FN. Foundations of Behavioral Research, 3rd ed. New York, NY: Holt, Rinehart, and Winston; 1986.
  • 10
    Eheman CR,Benard VB,Blackman D, et al. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control. 2006; 17: 2938.
  • 11
    Benard VB,Eheman CR,Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001. Obstet Gynecol. 2004; 103: 564571.
  • 12
    Gold MR,Siegel JE,Russell L.B,Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
  • 13
    Centers for Disease Control and Prevention, National Breast and Cervical Cancer Early Detection Program. Policies and Procedures Manual. Atlanta, Ga: Centers for Disease Control and Prevention; 2005.
  • 14
    Critchfield GC,Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making. 1986; 6: 8592.
  • 15
    Doubilet P,Begg CB,Weinstein MC,Braun P,McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985; 5: 157177.
  • 16
    Dittus RS,Roberts SD,Wilson JR. Quantifying uncertainty in medical decisions. J Am Coll Cardiol. 1989; 14(3 suppl A ): 23A28A.
  • 17
    Benoit RM,Naslund MJ. An economic rationale for prostate cancer screening. Urology. 1994; 44: 795803.
  • 18
    O'Malley AS,Lawrence W,Liang W, et al. Feasibility of mobile cancer screening and prevention. J Health Care Poor Underserved. 2002; 13: 298319.
  • 19
    Rubin E,Mennemeyer ST,Desmond RA, et al. Reducing the cost of diagnosis of breast carcinoma: impact of ultrasound and imaging-guided biopsies on a clinical breast practice. Cancer. 2001; 91: 324332.
  • 20
    Lindfors KK,Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA. 1995; 274: 881884.
  • 21
    Salzmann P,Kerlikowske K,Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med. 1997; 127: 955965.
  • 22
    Mandelblatt JS,Schechter CB,Yabroff KR, et al. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005; 20: 487496.
  • 23
    Helms LJ,Melnikow J. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment. Med Care. 1999; 37: 652661.
  • 24
    Maxwell GL,Carlson JW,Ochoa M,Krivak T,Rose GS,Myers ER. Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstet Gynecol. 2002; 100: 740748.
  • 25
    Mandelblatt JS,Lawrence WF,Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002; 287: 23722381.
  • 26
    Kulasingam SL,Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003; 290: 781789.
  • 27
    Fetters MD,Lieberman RW,Abrahamse PH,Sanghvi RV,Sonnad SS. Cost-effectiveness of Pap smear screening for vaginal cancer after total hysterectomy for benign disease. J Low Genit Tract Dis. 2003; 7: 194202.
  • 28
    Goldie SJ,Kim JJ,Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004; 103: 619631.
  • 29
    Schweitzer ME,French MT,Ullmann SG,McCoy CB. Cost-effectiveness of detecting breast cancer in lower socioeconomic status African American and Hispanic women through mobile mammography services. Med Care Res Rev. 1998; 55: 99115.
  • 30
    Hurley SF,Livingston PM,Thane N,Quang L. Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia. J Epidemiol Commun Health. 1994; 48: 391399.
  • 31
    Gerard K,Salkeld G,Hall J. Counting the costs of mammography screening: first year results from the Sydney study. Med J Aust. 1990; 152: 466, 469–471.
  • 32
    Bonfill X,Marzo M,Pladevall M,Marti J,Emparanza JI. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev. 2001; 1: CD002943.
  • 33
    Legler J,Meissner HI,Coyne C,Breen N,Chollette V,Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002; 11: 5971.
  • 34
    Marcus AC,Crane LA. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med. 1998; 27: 1331.
  • 35
    Meissner HI,Breen N,Coyne C,Legler JM,Green D,Edwards BK. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998; 7: 951961.
  • 36
    Snell JL,Buck EL. Increasing cancer screening: a meta-analysis. Prev Med. 1996; 25: 702707.
  • 37
    Stone EG,Morton SC,Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002; 136: 641651.
  • 38
    Yabroff KR,Mandelblatt JS. Interventions targeted toward patients to increase mammography use. Cancer Epidemiol Biomarkers Prev. 1999; 8: 749757.
  • 39
    Breen N,Wagener DK,Brown ML,Davis WW,Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 17041713.
  • 40
    Fajardo LL,Saint-Germain M,Meakem TJ3rd,Rose C,Hillman BJ. Factors influencing women to undergo screening mammography. Radiology. 1992; 184: 5963.
  • 41
    Mandelblatt JS,Gold K,O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med. 1998; 28: 418425.
  • 42
    Friedman LC,Woodruff A,Lane M,Weinberg AD,Cooper HP,Webb JA. Breast cancer screening behaviors and intentions among asymptomatic women 50 years of age and older. Am J Prev Med. 1995; 11: 219223.
  • 43
    Haggerty J,Tamblyn R,Abrahamowicz M,Beaulieu MD,Kishchuk N. Screening mammography referral rates for women ages 50 to 69 years by recently licensed family physicians: physician and practice environment correlates. Prev Med. 1999; 29: 391404.
  • 44
    Frazier EL,Jiles RB,Mayberry R. Use of screening mammography and clinical breast examinations among black, Hispanic, and white women. Prev Med. 1996; 25: 118125.
  • 45
    Lane DS,Zapka J,Breen N,Messina CR,Fotheringham DJ. A systems model of clinical preventive care: the case of breast cancer screening among older women.For the NCI Breast Cancer Screening Consortium. Prev Med. 2000; 31: 481493.